WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 68.90
+0.30 (0.44%)
May 8, 2026, 1:30 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.13 billion as of May 8, 2026. Its market cap has increased by 11.31% in one year.
Market Cap
3.13B
Enterprise Value
3.65B
Revenue
1.11B
Ranking
n/a
PE Ratio
15.23
Stock Price
68.90
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.13B, a decrease of -8.65%. That is a compound annual growth rate of -3.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.13B | -6.13% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hi-Clearance | 6.01B |
| Delta Asia International | 5.10B |
| Bonraybio | 3.99B |
| Medimaging Integrated Solution | 2.66B |
| A Plus Biotechnology | 2.50B |
| Applied BioCode | 2.32B |
| Wellell | 2.24B |
| Dynamic Medical Technologies | 2.21B |